Cash on Hand for STERIS (STE)
According to STERIS's latest reported financial statements, the company's latest reported cash and short-term investments is $423.70M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingCash on HandSwitch metric
Latest period
$423.70M
YoY change
-17.1%
5Y CAGR
-11.7%
Peak year (2022)
$348.32M
Latest annual
$171.70M
Cash on Hand history chart for STERIS (STE) from 1991 to 2025
Cash on Hand history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $171.70M | -17.1% | ||
| 2024 | $207.02M | -0.6% | ||
| 2023 | $208.36M | -40.2% | ||
| 2022 | $348.32M | +57.9% | ||
| 2021 | $220.53M | -31.0% | ||
| 2020 | $319.58M | +44.8% | ||
| 2019 | $220.63M | +9.5% | ||
| 2018 | $201.53M | -28.8% | ||
| 2017 | $282.92M | +13.7% | ||
| 2016 | $248.84M | +48.4% | ||
| 2015 | $167.69M | +9.7% | ||
| 2014 | $152.80M | +7.6% | ||
| 2013 | $142.01M | -5.8% | ||
| 2012 | $150.82M | -21.9% | ||
| 2011 | $193.02M | -10.2% | ||
| 2010 | $214.97M | +39.4% | ||
| 2009 | $154.18M | +197.3% | ||
| 2008 | $51.87M | -0.8% | ||
| 2007 | $52.30M | -28.1% | ||
| 2006 | $72.73M | +177.8% | ||
| 2005 | $26.18M | -67.4% | ||
| 2004 | $80.41M | +210.0% | ||
| 2003 | $25.94M | +108.8% | ||
| 2002 | $12.42M | -49.7% | ||
| 2001 | $24.71M | -30.3% | ||
| 2000 | $35.48M | +49.7% | ||
| 1999 | $23.70M | +38.0% | ||
| 1998 | $17.17M | -16.6% | ||
| 1997 | $20.60M | +10200.0% | ||
| 1996 | $200,000 | -87.5% | ||
| 1995 | $1.60M | -40.7% | ||
| 1994 | $2.70M | -86.4% | ||
| 1993 | $19.90M | +1890.0% | ||
| 1992 | $1.00M | +233.3% | ||
| 1991 | $300,000 | — |
Cash on Hand values are taken from STERIS's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of STERIS (STE) cash and short-term investments is $171.70M – declined 17.1% year-over-year.
Across 2020–2025 (5 years), STERIS cash and short-term investments produced a CAGR of -11.7% – with a net decline across the window.
Between 2022 and 2025, STERIS cash and short-term investments plunged 50.7%, falling from $348.32M to $171.70M.
$348.32M stands as the all-time-high annual cash and short-term investments, posted in 2022, against a low of $200,000 during 1996.
Within Healthcare, STERIS (STE) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
STERIS Cash on Hand by Year
STERIS Cash on Hand 2025: $171.70M
STERIS cash and short-term investments in 2025 was $171.70M, declined 17.1% below 2024.
STERIS Cash on Hand 2024: $207.02M
STERIS cash and short-term investments in 2024 was $207.02M, edged down 0.6% below 2023.
STERIS Cash on Hand 2023: $208.36M
STERIS cash and short-term investments in 2023 was $208.36M, plunged 40.2% below 2022.
STERIS Cash on Hand 2022: $348.32M
STERIS cash and short-term investments in 2022 was $348.32M, surged 57.9% from 2021. This figure represents the highest annual value in the available history.
STERIS Cash on Hand 2021: $220.53M
STERIS cash and short-term investments in 2021 was $220.53M.
See more financial history for STERIS (STE).
Sector peers — Cash on Hand
Companies in the same sector as STERIS, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is STERIS's cash and short-term investments?
- Latest reported cash and short-term investments for STERIS (STE) is $423.70M (period ending December 31, 2025).
How has STERIS cash and short-term investments changed year-over-year?
- STERIS (STE) cash and short-term investments changed -17.1% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS cash and short-term investments?
- STERIS (STE) cash and short-term investments compound annual growth rate is -11.7% over the most recent 5 years available.
When did STERIS cash and short-term investments hit its highest annual value?
- STERIS cash and short-term investments reached its highest annual value of $348.32M in 2022.
What was STERIS cash and short-term investments in 2024?
- STERIS (STE) cash and short-term investments in 2024 was $207.02M.
What was STERIS cash and short-term investments in 2025?
- STERIS (STE) cash and short-term investments in 2025 was $171.70M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.